Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nabil El-Sherif

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Circulation|June 21, 2021
Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart AssociationYerem Yeghiazarians, Hani Jneid, Jeremy R Tietjens, et al.
Plos One|December 7, 2018
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammationAdemuyiwa S Aromolaran, Ujala Srivastava, Alessandra Alí, et al.
Journal of the American Heart Association|February 3, 2021
Risk of QTc Interval Prolongation Associated With Circulating Anti-Ro/SSA Antibodies Among US Veterans: An Observational Cohort StudyPietro Enea Lazzerini, Gabriele Cevenini, Yongxia Sarah Qu, et al.
Journal of the American College of Cardiology|April 21, 2012
Microvolt T-wave alternans testing has a role in arrhythmia risk stratificationRichard L Verrier, Thomas Klingenheben, Marek Malik, et al.
Journal of the American College of Cardiology|September 17, 2011
Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive ElectrocardiologyRichard L Verrier, Thomas Klingenheben, Marek Malik, et al.
Frontiers in Cardiovascular Medicine|October 6, 2016
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory ArthritisPietro Enea Lazzerini, Pier Leopoldo Capecchi, Iacopo Bertolozzi, et al.
Frontiers in Pharmacology|June 2, 2020
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de PointesPietro Enea Lazzerini, Iacopo Bertolozzi, Maurizio Acampa, et al.
Circulation. Arrhythmia and Electrophysiology|April 1, 2016
Arrhythmogenicity of Anti-Ro/SSA Antibodies in Patients With Torsades de PointesPietro Enea Lazzerini, Yuankun Yue, Ujala Srivastava, et al.
Heart (British Cardiac Society)|May 12, 2017
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointesPietro Enea Lazzerini, Franco Laghi-Pasini, Iacopo Bertolozzi, et al.
Circulation. Arrhythmia and Electrophysiology|June 18, 2021
Proton Pump Inhibitors Directly Block hERG-Potassium Channel and Independently Increase the Risk of QTc Prolongation in a Large Cohort of US VeteransPietro Enea Lazzerini, Alessandra Cartocci, Yongxia Sarah Qu, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Circulation|June 21, 2021
Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart AssociationYerem Yeghiazarians, Hani Jneid, Jeremy R Tietjens, et al.
Plos One|December 7, 2018
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammationAdemuyiwa S Aromolaran, Ujala Srivastava, Alessandra Alí, et al.
Journal of the American Heart Association|February 3, 2021
Risk of QTc Interval Prolongation Associated With Circulating Anti-Ro/SSA Antibodies Among US Veterans: An Observational Cohort StudyPietro Enea Lazzerini, Gabriele Cevenini, Yongxia Sarah Qu, et al.
Journal of the American College of Cardiology|April 21, 2012
Microvolt T-wave alternans testing has a role in arrhythmia risk stratificationRichard L Verrier, Thomas Klingenheben, Marek Malik, et al.
Journal of the American College of Cardiology|September 17, 2011
Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive ElectrocardiologyRichard L Verrier, Thomas Klingenheben, Marek Malik, et al.
Frontiers in Cardiovascular Medicine|October 6, 2016
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory ArthritisPietro Enea Lazzerini, Pier Leopoldo Capecchi, Iacopo Bertolozzi, et al.
Frontiers in Pharmacology|June 2, 2020
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de PointesPietro Enea Lazzerini, Iacopo Bertolozzi, Maurizio Acampa, et al.
Circulation. Arrhythmia and Electrophysiology|April 1, 2016
Arrhythmogenicity of Anti-Ro/SSA Antibodies in Patients With Torsades de PointesPietro Enea Lazzerini, Yuankun Yue, Ujala Srivastava, et al.
Heart (British Cardiac Society)|May 12, 2017
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointesPietro Enea Lazzerini, Franco Laghi-Pasini, Iacopo Bertolozzi, et al.
Circulation. Arrhythmia and Electrophysiology|June 18, 2021
Proton Pump Inhibitors Directly Block hERG-Potassium Channel and Independently Increase the Risk of QTc Prolongation in a Large Cohort of US VeteransPietro Enea Lazzerini, Alessandra Cartocci, Yongxia Sarah Qu, et al.
Pageof 8